Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNYSEReal EstateReit - DiversifiedSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NXDT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain consistent dividend payments | The company has a clear plan to maintain dividend payments despite current losses. | Intact | dividends are cut or suspended | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 6 of last 6 quarters. Dividend per share has consistently remained at $0.15 from 2024-Q3 through 2026-Q2. This stable dividend payment reflects management's ongoing commitment to maintaining dividends, delivering on this capital allocation priority. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
NXDT is a higher-risk real estate turnaround and M&A story, not yet a proven durable compounder. Its multi-year view is cautious: operating income has improved, but the company remains loss-making and recent performance is below its industry cohort.
The valuation evidence points to NXDT being cheap versus peers, with an expectations gap of 0.31 and medium model confidence. That does not by itself support the thesis, since the priced-in tag is unjustified and the evidence does not explain what specific expectations the market has already set.
Near-term, management’s stated priorities show mixed execution: operating income improved from a loss in 2024-Q3 to positive income in 2026-Q2, and the dividend per share stayed unchanged through 2026-Q2, while recent M&A engagement is still developing. The latest signal shifted to cautious as company quality fell, and another earnings miss could add pressure; the evidence also flags elevated risk.
The multi-year case would be helped if management keeps improving operating income and its M&A agreements support the business. Near-term, lower interest rates could help the real estate sector, while weakening results at sector bellwethers or another NXDT miss could remove support.
Over the next 1 to 3 years, NXDT’s thesis depends on continued operating progress and credible results from its M&A activity, against a backdrop of losses and elevated risk. The evidence supports a cautious watch state, not a settled turnaround. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Operating income improves to positive territory | NXDT is improving its operating income, turning from a loss of $3.45M in 2025-Q4 to a positive $3.45M in 2026-Q1. | Intact | operating income falls below $0 in any quarter after 2026-Q1 | Operating income: $2.116M FY2026-Q2; GAAP. Published target: >= $3.45M operating income. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 14, 20262,116,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful execution of M&A agreements | Recent positive M&A agreements show strategic moves to strengthen its portfolio. | Intact | M&A deals fail or are abandoned | M&A execution on track Company closed the Bradenton property sale and entered new material definitive agreements in 2026, indicating active and successful M&A execution. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.